Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population

Ralph Green, Joshua W. Miller

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged ≥ 60 years. Hyperhomocysteinemia (> 13 μmol/L) was observed in 16.5% of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7% for total B12 < 148 pmol /L, 36.4% for holotranscobalamin < 35 pmol/L, and 41.4% for creatinine > 115 μmol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3% for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.

Original languageEnglish (US)
Pages (from-to)1048-1051
Number of pages4
JournalClinical Chemistry and Laboratory Medicine
Volume43
Issue number10
DOIs
StatePublished - Oct 2005

Fingerprint

Vitamin B 12 Deficiency
Hyperhomocysteinemia
Vitamin B 12
Folic Acid
Population
Blood
Cells
Erythrocytes
Independent Living
Homocysteine
Hispanic Americans
Creatinine
Serum

Keywords

  • Folate
  • Fortification
  • Homocysteine
  • PAR%, population attributable risk percentage
  • SALSA, Sacramento Area Latino Study on Aging
  • Transcobalamin
  • Vitamin B

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. / Green, Ralph; Miller, Joshua W.

In: Clinical Chemistry and Laboratory Medicine, Vol. 43, No. 10, 10.2005, p. 1048-1051.

Research output: Contribution to journalArticle

@article{4807891d5fc44197a72e6cac6ccc442d,
title = "Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population",
abstract = "Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged ≥ 60 years. Hyperhomocysteinemia (> 13 μmol/L) was observed in 16.5{\%} of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7{\%} for total B12 < 148 pmol /L, 36.4{\%} for holotranscobalamin < 35 pmol/L, and 41.4{\%} for creatinine > 115 μmol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3{\%} for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.",
keywords = "Folate, Fortification, Homocysteine, PAR{\%}, population attributable risk percentage, SALSA, Sacramento Area Latino Study on Aging, Transcobalamin, Vitamin B",
author = "Ralph Green and Miller, {Joshua W.}",
year = "2005",
month = "10",
doi = "10.1515/CCLM.2005.183",
language = "English (US)",
volume = "43",
pages = "1048--1051",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "10",

}

TY - JOUR

T1 - Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population

AU - Green, Ralph

AU - Miller, Joshua W.

PY - 2005/10

Y1 - 2005/10

N2 - Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged ≥ 60 years. Hyperhomocysteinemia (> 13 μmol/L) was observed in 16.5% of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7% for total B12 < 148 pmol /L, 36.4% for holotranscobalamin < 35 pmol/L, and 41.4% for creatinine > 115 μmol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3% for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.

AB - Prevalence rates for folate deficiency and hyperhomocysteinemia have been markedly reduced following the introduction of folic acid fortification in the United States. We report the prevalence of hyperhomocysteinemia in a population of community-dwelling elderly Latinos in the post-folic acid fortification era. We measured homocysteine, total vitamin B12, holotranscobalamin, red blood cell folate, and serum creatinine in 1096 subjects aged ≥ 60 years. Hyperhomocysteinemia (> 13 μmol/L) was observed in 16.5% of the subjects. The population attributable risk percentages for hyperhomocysteinemia were 29.7% for total B12 < 148 pmol /L, 36.4% for holotranscobalamin < 35 pmol/L, and 41.4% for creatinine > 115 μmol/L. In contrast, the population attributable risk percentage for hyperhomocysteinemia was only 0.3% for red blood cell folate <365 nmol/L. We conclude that in the post-folic acid fortification era, low vitamin B12 status has become the dominant nutritional determinant of hyperhomocysteinemia. Steps to either reduce the prevalence of vitamin B12 deficiency or to identify and treat individuals with vitamin B12 deficiency could further reduce the prevalence of hyperhomocysteinemia.

KW - Folate

KW - Fortification

KW - Homocysteine

KW - PAR%, population attributable risk percentage

KW - SALSA, Sacramento Area Latino Study on Aging

KW - Transcobalamin

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=27744463119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744463119&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2005.183

DO - 10.1515/CCLM.2005.183

M3 - Article

C2 - 16197296

AN - SCOPUS:27744463119

VL - 43

SP - 1048

EP - 1051

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 10

ER -